NCOA3 and endometrial carcinoma: Although there is no evidence showing the role of SRC-3 in the pathogenesis of endometrial carcinoma, several clinical studies have investigated the expression of SRC-3 in endometrial carcinoma and its effect on prognosis of this disease.